Boys Arnold & Co. Inc. raised its position in Clorox Company (The) (NYSE:CLX) by 0.0% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 9,422 shares of the company’s stock after buying an additional 2 shares during the period. Boys Arnold & Co. Inc.’s holdings in Clorox Company (The) were worth $1,255,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of CLX. BlackRock Inc. raised its position in shares of Clorox Company (The) by 1,402.2% in the first quarter. BlackRock Inc. now owns 10,390,206 shares of the company’s stock worth $1,400,912,000 after buying an additional 9,698,542 shares during the period. Parnassus Investments CA acquired a new position in shares of Clorox Company (The) during the first quarter worth approximately $434,255,000. Vanguard Group Inc. raised its position in shares of Clorox Company (The) by 4.8% in the first quarter. Vanguard Group Inc. now owns 14,164,716 shares of the company’s stock worth $1,909,829,000 after buying an additional 649,766 shares during the period. Morgan Stanley raised its position in shares of Clorox Company (The) by 31.9% in the first quarter. Morgan Stanley now owns 996,369 shares of the company’s stock worth $134,342,000 after buying an additional 241,210 shares during the period. Finally, WINTON GROUP Ltd raised its position in shares of Clorox Company (The) by 762.4% in the first quarter. WINTON GROUP Ltd now owns 228,197 shares of the company’s stock worth $28,566,000 after buying an additional 201,737 shares during the period. Institutional investors own 69.83% of the company’s stock.

Shares of Clorox Company (NYSE CLX) traded up 0.37% during trading on Friday, hitting $137.48. 367,640 shares of the stock traded hands. The company has a 50 day moving average price of $134.18 and a 200 day moving average price of $134.70. The firm has a market cap of $17.74 billion, a price-to-earnings ratio of 25.77 and a beta of 0.40. Clorox Company has a 12 month low of $111.24 and a 12 month high of $141.76.

Clorox Company (The) (NYSE:CLX) last issued its earnings results on Thursday, August 3rd. The company reported $1.53 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.49 by $0.04. Clorox Company (The) had a net margin of 11.74% and a return on equity of 190.67%. The company had revenue of $1.65 billion for the quarter, compared to analysts’ expectations of $1.65 billion. During the same period in the prior year, the business earned $1.30 EPS. The firm’s quarterly revenue was up 2.9% on a year-over-year basis. Analysts anticipate that Clorox Company will post $5.67 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “Boys Arnold & Co. Inc. Acquires 2 Shares of Clorox Company (The) (CLX)” was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this report on another publication, it was illegally stolen and republished in violation of United States & international copyright laws. The original version of this report can be viewed at https://www.thecerbatgem.com/2017/08/26/boys-arnold-co-inc-acquires-2-shares-of-clorox-company-the-clx.html.

CLX has been the topic of a number of recent research reports. BMO Capital Markets reiterated a “buy” rating and set a $136.00 price target on shares of Clorox Company (The) in a report on Thursday, May 4th. Jefferies Group LLC set a $138.00 price target on shares of Clorox Company (The) and gave the stock a “hold” rating in a report on Wednesday, May 3rd. BidaskClub lowered shares of Clorox Company (The) from a “hold” rating to a “sell” rating in a report on Wednesday, July 5th. Deutsche Bank AG restated a “hold” rating and issued a $137.00 target price (up previously from $126.00) on shares of Clorox Company (The) in a report on Saturday, July 22nd. Finally, Royal Bank Of Canada restated a “hold” rating and issued a $115.00 target price on shares of Clorox Company (The) in a report on Friday, June 30th. Two research analysts have rated the stock with a sell rating, ten have issued a hold rating and three have issued a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average target price of $129.05.

In other Clorox Company (The) news, EVP James E. Foster sold 9,861 shares of the stock in a transaction dated Wednesday, August 23rd. The shares were sold at an average price of $138.51, for a total transaction of $1,365,847.11. Following the completion of the sale, the executive vice president now directly owns 22,069 shares of the company’s stock, valued at $3,056,777.19. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, SVP Jon M. Balousek sold 9,223 shares of the stock in a transaction dated Wednesday, August 23rd. The shares were sold at an average price of $138.87, for a total transaction of $1,280,798.01. Following the sale, the senior vice president now directly owns 20,614 shares of the company’s stock, valued at $2,862,666.18. The disclosure for this sale can be found here. 0.74% of the stock is owned by corporate insiders.

About Clorox Company (The)

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Company (The) (NYSE:CLX).

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Stock Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related stocks with our FREE daily email newsletter.